PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

201961 citationsJournal Articlegold Open Access

Authors

EU Clinical Trials Register: EudraCT 2016-001569-97 , registered on 19-6-2017. Clinicaltrials.gov: NCT03192059 , registered on 19-6-2017.

Published in: BMC Cancer

Volume 19, Issue 1, pp. 506-506

Field-Weighted Citation Impact: 3.64